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Abstract
Background: Moyamoya disease (MMD) is a known progressive obstructive cerebrovascular disorder. Monitoring and managing
mood and stress are critical for patients with MMD, as they affect clinical outcomes. The ecological momentary assessment
(EMA) method is a longitudinal study design by which multiple variable assessments can be performed over time to detect
momentary fluctuations and changes in psychological dimensions such as mood and stress over time.
Objective: This study aimed to identify predicting factors associated with momentary mood and stress at both the within-person
and between-person levels and to examine individual fluctuation of mood over time in the short term using an EMA method
combined with a mobile phone app.
Methods: Participants aged older than 18 years were recruited from a tertiary hospital in Seoul, Korea, between July 2018 and
January 2019. The PsyMate scale for negative affect (NA) and positive affect (PA) and the Trier Inventory for Chronic Stress
Scale were uploaded on patient mobile phones. Using a mobile app, data were collected four times a day for 7 days. Pearson
correlations and mixed modeling were used to predict relationships between repeatedly measured variables at both the
between-person and within-person levels.
Results: The mean age of the 93 participants was 40.59 (SD 10.06) years, 66 (71%) were female, and 71 (76%) were married.
Participants provided 1929 responses out of a possible 2604 responses (1929/2604, 74.08%). The mean momentary NA and PA
values were 2.15 (SD 1.12) and 4.70 (SD 1.31) out of 7, respectively. The momentary stress value was 2.03 (SD 0.98) out of 5.
Momentary NA, PA, and stress were correlated (P<.001) and varied over time in relation to momentary variables. Common
momentary variables associated with momentary mood and stress at both the within-person (level 1) and between-person (level
2) levels were identified. Momentary NA increased when being alone and being at the hospital at both levels, whereas momentary
PA increased when eating or drinking, resting, being at a café, restaurant or a public place but decreased when being alone at
both levels. Momentary stress increased when being at the office, at a public place, or as the time of the day went by but decreased
when resting or during the weekend. Different factors affecting mood and stress at different levels were identified. Fluctuations
in individual momentary mood over time at the within-person level were captured.
Conclusions: The EMA method using a mobile phone app demonstrated its ability to capture changes in mood and stress in
various environmental contexts in patients with MMD. The results could provide baseline information for developing interventions
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to manage negative mood and stress of patients with MMD based on the identified predictors affecting mood and stress at two
different levels.
(JMIR Mhealth Uhealth 2020;8(5):e17034) doi: 10.2196/17034
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Introduction
Background
Moyamoya disease (MMD) is a rare idiopathic vascular disorder
that is characterized by progressive bilateral stenosis or
occlusion of the distal branches of the carotid arteries with an
abnormal vascular network [1,2]. It is associated with the
development of bifurcation and compensatory arterial collateral
networks at the base of the brain [1,2], hence the name
moyamoya (describing a puff of smoke in Japanese) [1]. MMD
is common in Asian countries, such as Korea and Japan, with
sparse observation in Europe and the Americas [3,4].
The prevalence of MMD in Korea has gradually increased and
reached 16.1 per 100,000 persons in 2011 [4]. This increase can
be partly explained by the increasing availability of diagnostic
tests, such as magnetic resonance (MR) imaging or MR
angiography and prolonged survival owing to improved
management [4,5]. In Japan, the prevalence rate was 6.03 per
100,000 persons in 2003 [6], and in Nanjing, China, the
prevalence rate was 3.92 per 100,000 persons in 2010 [7]. The
incidence rate of MMD in the United States was lower than that
in East Asian countries at 0.087 per 100,000 persons [8],
whereas moyamoya syndrome (MMS), termed unilateral
moyamoya angiopathy [9], is considered to have higher
prevalence in Western countries than in East Asian countries
[10]. The prevalence of MMS in Western countries was found
to be close to that in Japan at 0.34 per 100,000 persons in a
nationwide survey [11]. The relatively high prevalence of MMS
in Western countries may be related to the fact that sickle cell
disease is a frequent cause of MMS in individuals of African
origin living in the United States and Europe [12,13].
The clinical features of MMD or MMS in adult patients
generally involve cerebral hemorrhages and infarction, whereas
children develop ischemic attacks [4]. Relating to the disease’s
chronic and uncertain nature, it has been observed that improper
management of mood and stress can lead to reduced
cerebrovascular blood flow, which is closely related to the
prognosis of the disease [14]. According to recent studies, adults
with MMD are vulnerable to stress and mood changes [14] and
may have anxiety, depression, and posttraumatic stress syndrome
[15].
Mood is a state of subjective feeling that can be changed by
events and is typically described as having either positive or
negative valences [16]. Individual differences exist in
experiencing the states of positive and negative feelings, and
these are assessed as positive and negative effects [17]. Negative
mood states such as depression can extend to psychosocial
distress that potentially leads to stress and, more generally, to
a negative outlook on life [18,19]. Mood and stress vary with
time in relation to the surrounding context, showing changes
over time and interindividual differences [20].
The ecological momentary assessment (EMA) method, also
known as the experience sample method or ambulatory
assessment, is a repeated observational study design by which
time-varying variables can be assessed in natural and real-life
environments [20-22]. For example, participants self-report
their mood or anxiety multiple times to observe changes based
on the environment and/or time while performing their ordinary
daily tasks, without changing their life patterns to attend a survey
[23]. Participants can also report various events, types of food,
and calories per serving multiple times per day to track down
changes in their eating behavior over days or weeks [24]. Such
reports can be completed through diaries, personal digital
assistants, mobile apps, or wearable sensors [25] in the short or
long term, depending on the study goals and design [26]. This
method is reportedly accurate and able to detect changes in
psychological properties through multiple daily assessments
[27,28], helps address questions regarding individual differences
[29], and elucidates momentary changes and fluctuations in
psychological dimensions such as mood and stress over time
and across situations [30,31]. It has been widely used to assess
the psychological characteristics of participants with [32,33]
and without [26] mental problems. Recently, various tools using
mobile phone technology have been developed and used to
measure mood and stress in diverse patient populations [26];
thus, this study utilized the EMA approach for moyamoya
patients’ condition.
Objectives
This study aimed to identify predicting factors associated with
momentary mood and stress at both the within-person and
between-person levels and to examine individual fluctuation of
mood over time in the short term using an EMA method
combined with a mobile phone app.
Methods
Participants
Adult patients with MMD, who visited the outpatient clinic of
a tertiary hospital or were admitted in the same hospital, were
recruited from July 2018 to January 2019. Only participants
who used Android operating systems were included, as the
developed mobile app was only available for this operating
system with the version 4.4 or higher as described in a previous
study [32]. To exclude possible cognitive impairment that would
preclude the participants from answering the questionnaire, all
patients were required to have a score higher than 24 on the
Korean version of the Mini-Mental State Examination [33],
which is widely used to test the cognitive ability of clinical
populations in Korea. This study was approved by the
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institutional review board of the Yonsei University Health
System (approval number: 4-2018-0385), and informed consent
was obtained from each participant.
Measurements
Measurements in this study included baseline variables, such
as demographic characteristics, disease-specific information,
trait mood (anxiety and depression), and trait stress. Momentary
measures were mood and stress. The study variables at baseline
and momentary measures are summarized in Table 1.
Table 1. Study variables at all time points.
Ecological momentary assessmentBaselineVariables
Day 7Day 6Day 5Day 4Day 3Day 2Day 1
N/AN/AN/AN/AN/AN/AN/AaxDemographic characteristics
N/AN/AN/AN/AN/AN/AN/AxDisease-specific information
N/AN/AN/AN/AN/AN/AN/AxKorean Hospital Anxiety and Depression Scale
N/AN/AN/AN/AN/AN/AN/AxKorean Perceived Stress Scale
xxxxxxxN/AMomentary mood (PsyMate)
xxxxxxxN/AMomentary stress (Trier Inventory for Chronic Stress)
ax: variables measured at the day point.
bN/A: not applicable.
Baseline Measures
Patients provided demographic information such as age, sex,
income, level of education, symptoms experienced, and disease
duration since the diagnosis. The perceived severity of the
disease was also self-reported at baseline using a 5-point scale.
We used the Korean version of the Hospital Anxiety and
Depression Scale (K-HADS) [34] to measure trait mood after
obtaining the permission of the scale provider. The HADS is
known as a reliable and valid scale and used worldwide for
measuring mental health in clinical settings [35]. The Cronbach
alphas of the K-HADS anxiety and depression subscales have
been reported to be .89 and .86, respectively [35]. The scale
consists of 14 items, 7 items for assessing anxiety and 7 items
for depression, measured on a 4-point scale, from 0 to 3. A
higher score denotes a higher level of anxiety or depression.
The Cronbach alphas for the anxiety and depression subscales
in this study were .75 and .81, respectively.
To measure trait stress, we used the Korean version of the
Perceived Stress Scale, which consists of 10 items [36]. This
scale was freely downloaded from the official homepage of the
Laboratory for the Study of Stress, Immunity, and Disease of
the Carnegie Mellon University. It has negative and positive
subdomains and five negative items for stress and five positive
items for coping ability rated on a 5-point Likert scale (0–4).
The Cronbach alphas of the two subdomains have been reported
to be .87 and .71, respectively [36]. The Cronbach alpha in this
study was .89 for both subdomains.
Momentary Measures Using a Mobile App
Momentary mood was measured using the Korean version of
the PsyMate, translated from the English version with reference
to the original Dutch version. We obtained permission to use
PsyMate from the developers [37]. It consists of nine items
assessing negative affect (NA) and four items assessing positive
affect (PA). The Cronbach alphas of the subscales of NA and
PA were .91 and .92, respectively, in the previous study [37].
The Cronbach alphas in this study were .94 and .92 for NA and
PA, respectively.
Stress was assessed by the Korean version of the Trier Inventory
for Chronic Stress, adapted from the German version [38,39].
It consists of eight items measuring work overload, social
overload, pressure to perform, work discontent, excessive
demands from work, lack of social recognition, social tensions,
and social isolation. The Cronbach alpha in this study was .79.
The questionnaires were uploaded on a mobile app for the
Android operating system developed in the previous study [32].
Momentary mood and stress were measured in an environmental
context considering what the participants were doing, where
they were, and with whom they were at the moment of
answering.
Procedure
After obtaining participant informed consent, we held an
individual and face-to-face 30-min intake session with each
patient. Patients filled the baseline measures and were allowed
time to download the app and practice answering for the EMA
study. Researchers helped the participants answer the baseline
survey and install the app. Patients were provided a reward in
coupons when they completed the baseline survey and
enrollment. They were also informed that they would receive
additional coupons on completion of the EMA study.
Researchers preset the survey period for each patient in advance
to push notifications and instructed participants to carry their
mobile phone during the scheduled survey period and to answer
the survey question when they received the notification
requesting them to do so.
Measures of mood and stress were set on the mobile app, and
notifications were set to appear four times a day for 7
consecutive days (4 times ×7 days=28 times/person) in
semirandom, 90-min blocks. Notifications were sent in the
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morning between 8 AM and 9 PM, early afternoon between
noon and 1 PM, evening between 5 PM and 6 PM, and at night
between 9 PM and 10 PM. Participants were instructed that they
would receive a reminder notification when they did not input
the response within 45 min after they received the first
notification for each scheduled measurement. Researchers
monitored participant compliance to the protocol and managed
participation by phoning patients who did not respond on the
first day and attempted to solve any participation difficulties
and problems in the EMA study.
Statistical Analysis
Data analysis was performed with STATA 14.0 (StataCorp)
using 1929 responses from 93 participants who provided more
than three responses in the total course of the study to capture
changes over time [20]. We analyzed participant characteristics
by descriptive analysis. Independent t tests and analysis of
variance were used to compare the mean differences between
the variable groups. We estimated the Pearson coefficient to
examine the correlation between the momentary variables.
Mixed modeling analysis, handling the clustered and correlated
data [20], was used to describe and predict factors associated
with momentary NA, PA, and stress at both the within-person
(level 1) and between-person (level 2) levels. The threshold of
statistical significance was set at P<.05.
Results
Participants
A total of 93 participants with MMD were recruited. Of 93
participants, 71 (76%) were recruited from the outpatient
department and 22 participants (24%) were recruited from the
admission wards of a university hospital. The mean age of the
participants was 40.59 years (SD 10.06), 71% (66/93)
participants were female, and 76% (71/93) participants were
married. The mean number of years since diagnosis was 3.68
(SD 4.05), and the perceived severity level was 3.56 (SD 1.00)
out of 5. The mean HADS anxiety and depression scores were
7.17 (SD 3.38) and 7.14 (SD 3.51) out of 21, respectively, and
the mean perceived stress level was 1.64 (SD .98) out of 4. The
participant baseline characteristics are summarized in Table 2.
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Table 2. Participant characteristics at baseline (n=93).
Possible rangeMean (SD)n (%)Characteristics
Age (years)
N/Aa40.59 (10.06)11 (12)20–29
N/AN/A37 (40)30–39
N/AN/A26 (28)40–49
N/AN/A15 (16)50–59
N/AN/A4 (4)≥60
Sex
N/AN/A66 (71)Female
N/AN/A27 (29)Male
Marital status
N/AN/A71 (76)Married
N/AN/A22 (24)Not married
Education
N/AN/A41 (44)≤High school
N/AN/A52 (56)≥College
Monthly household incomeb (US $)
N/AN/A23 (25)<2000
N/AN/A16 (18)2000–3000
N/AN/A22 (24)3000–4000
N/AN/A31 (33)>4000
N/A3.68 (4.05)N/AYears since the diagnosis
1–53.56 (1.00)N/APerceived severity
0–217.17 (3.38)N/AHADSc anxiety
0–217.14 (3.51)N/AHADS depression
0–41.64 (.98)N/APerceived stress
aN/A: not applicable.
bn=92.
cHADS: Hospital Anxiety and Depression Scale.
Momentary Responses
Participants provided 1929 responses out of a possible 2604
(1929/2604, 74.1%). Of 1883 responses, 799 (42.4%) were
answered while participants were resting, 344 responses (18.3%)
while working, 293 responses (15.6%) doing household work,
and 188 responses (10.0%) while eating or drinking at the
moment of answering. Of the 1929 responses, 1147 (59.5%)
were obtained when participants were at home, 325 responses
(16.9%) were obtained at the office, and 87 responses (4.5%)
were obtained at a café or restaurant. Of all 1929 responses,
444 (23.1%) were obtained while the participants were alone,
and 1348 (69.9%) were obtained on weekdays. Of 1929
responses, 489 (25.3%), 497 (25.8%), 509 (26.4%), and 434
(22.5%) were provided in the morning, afternoon, evening, and
at night, respectively. The mean momentary NA and PA were
2.15 (SD 1.12) and 4.70 (SD 1.31) out of 7, respectively. The
mean momentary stress level was 2.03 (SD .68) out of 5.
Measures of momentary variables are summarized in Table 3.
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Table 3. Measures of momentary variables (n=1929).
Possible rangeMean (SD)n (%)Momentary variables
Whata (things doing)
N/AN/Ab293 (15.6)Household work
N/AN/A344 (18.3)Working
N/AN/A188 (10.0)Eating/drinking
N/AN/A799 (42.4)Resting
N/AN/A259 (13.7)Other
Wherec (place being)
N/AN/A1147 (59.5)Home
N/AN/A325 (16.9)Office
N/AN/A87 (4.5)Café or restaurant
N/AN/A66 (3.4)Hospital
N/AN/A138 (7.2)Public place
N/AN/A164 (8.5)Other
Being alone
N/AN/A444 (23.1)Yes
N/AN/A1485 (76.9)No
Weekend
N/AN/A581 (30.1)Yes
N/AN/A1348 (69.9)No
Time of day
N/AN/A489 (25.3)Morning (8 AM to 9 PM)
N/AN/A497 (25.8)Afternoon (12 noon to 1 PM)
N/AN/A509 (26.4)Evening (5 PM to 6 PM)
N/AN/A434 (22.5)Night (9 PM to 10 PM)
1–72.15 (1.12)N/AMomentary negative affect
1–74.70 (1.31)N/AMomentary positive affect
1–52.03 (0.68)N/AMomentary stress
an=1883.
bN/A: not applicable.
cn=1927.
Correlations Between Momentary Negative Affect, Positive
Affect, and Stress
Momentary NA, PA, and stress were significantly correlated
(P<.001). Momentary NA was negatively correlated with
momentary PA (r=−0.607; P<.001) and positively with
momentary stress (r=0.538; P<.001). Momentary PA was
negatively correlated with momentary stress (r=−0.272; P<.001).
The correlation coefficients between variables are presented in
Table 4.
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Table 4. Correlation coefficients between momentary variables (n=93).
Momentary PAb (r value)Momentary NAa (r value)Momentary variables
-0.607c1Momentary NA
1−0.607cMomentary PA
−0.272c0.538cMomentary stress
aNA: negative affect.
bPA: positive affect.
cP<.001.
Modeling of Between-Person and Within-Person Analysis
Analysis by mixed modeling was performed based on 1929
completed assessments from the participants who provided more
than three responses for analyzing changes of momentary mood
and stress over time at both level 1 (within-person) and level 2
(between-person).
Momentary predicting factors were examined by three models
at levels 1 and 2. Disease-specific variables such as perceived
severity and years since the diagnosis, age, sex, and trait mood
variables at the baseline were added into models 2 and 3 for
adjustment. Momentary variables included things doing (what),
place being (where), being alone or not (with whom), answering
during the weekend or not, and time of day. Table 5 shows the
variables included in each model at both the within-person and
between-person levels.
Table 5. Designed levels, models, and variables.
VariablesLevel and model
Within-person
What, where, with whom, weekend, and time of day1. Momentary variables
Variables of Model 1 + perceived severity and years since the diagnosis2. Disease-specific variables
Variables of Model 2 + age, sex, trait anxiety/depression, and stress3. Trait variables
Between-person
What, where, with whom, weekend, and time of day1. Momentary variables
Variables of Model 1 + perceived severity and years since the diagnosis2. Disease-specific variables
Variables of Model 2 + age, sex, trait anxiety/depression, and stress3. Trait variables
Momentary Variables Affecting Momentary Mood and
Stress at the Within-Person and Between-Person Levels
Common momentary variables associated with momentary
mood and stress at both the within-person (level 1) and
between-person (level 2) levels were identified. Momentary
NA increased when being alone and being at the hospital at
both levels, whereas momentary PA increased when eating or
drinking, resting, being at a café or restaurant, or at the public
place but decreased when being alone at both levels. Momentary
stress increased when at the office, at the public place, or as the
time of the day went by but decreased when resting or during
the weekend.
Different factors affecting momentary mood and stress at
different levels were also identified. Variables of being at a café
or restaurant (coefficient=−0.19; P=.03) and during the weekend
(coefficient=−.08; P=.03) were associated with momentary NA
at the within-person level only. However, eating or drinking
(coefficient=−0.20; P=.04) and resting (coefficient=−0.21;
P=.01) were associated with momentary NA at the
between-person level only. There was no difference in factors
associated with momentary PA either at the within-person or
at the between-person level. Among variables, being at the
hospital (coefficient=5.67; P<.001) was associated with
momentary stress at the between-person level but not at the
within-person level. Table 6 shows the parameter estimates
from the mixed effect model at both levels.
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Table 6. Fixed effect model parameter estimates at within-person and between-person levels in model 3.
Momentary stress, coefficient (SE)Momentary positive affect, coefficient
(SE)
Momentary negative affect, coefficient
(SE)
Variablesa
BetweenWithinBetweenWithinBetweenWithin
What (things doing)
ReferenceReferenceReferenceReferenceReferenceReferenceHousehold work
0.64 (0.61)0.26 (0.42)−0.20 (0.15)−0.20 (0.12)0.08 (0.12)0.05 (0.09)Working
−0.56 (0.49)0.23 (0.33)0.27 (0.12)b0.24 (0.09)b−0.20 (0.10)b−0.09 (0.07)Eating or drinking
−1.56 (0.33)c−1.03 (0.23)c0.30 (0.08)c0.15 (0.06)b−0.21 (0.07)c−0.08 (0.05)Resting
−1.20 (0.45)−0.26 (0.31)−0.05 (0.11)0.03 (0.09)−0.02 (0.09)−0.01 (0.06)Other
Where (place being)
ReferenceReferenceReferenceReferenceReferenceReferenceHome
1.56 (0.58)c1.82 (0.41)c0.21 (0.14)−0.04 (0.11)−0.19 (0.12)0.05 (0.08)Office
−0.17 (0.61)−0.75 (0.42)0.33 (0.15)b0.37 (0.12)c−0.10 (0.12)−0.19 (0.09)bCafé or restaurant
5.67 (0.62)c0.60 (0.58)−0.07 (0.15)−0.17 (0.16)0.54 (0.12)c0.32 (0.12)bHospital
2.13 (0.47)c0.91 (0.33)c0.28 (0.12)b0.21 (0.09)b0.01 (0.09)−0.06 (0.07)Public place
0.83 (0.43)0.08 (0.30)0.35 (0.11)0.22 (0.08)−0.10 (0.09)−0.10 (0.06)Other
−0.34 (0.27)−0.37 (0.20)−0.49 (0.07)c−0.16 (0.05)c0.24 (0.05)c0.10 (0.04)bBeing alone
−0.76 (0.25)c−1.20 (0.16)c0.01 (0.06)0.02 (0.05)−0.03 (0.05)−0.08 (0.03)bWeekend
Time of day
ReferenceReferenceReferenceReferenceReferenceReference8-9 AM
0.77 (0.31)c0.76 (0.20)c0.08 (0.08)0.09 (0.06)−0.01 (0.06)−0.03 (0.04)12 noon-1 PM
1.03 (0.30)c1.07 (0.20)c−0.03 (0.08)0.03 (0.05)−0.01 (0.06)−0.04 (0.04)5-6 PM
1.40 (0.32)c1.48 (0.21)c0.14 (0.08)0.17 (0.06)c−0.05 (0.06)−0.04 (0.04)9-10 PM
0.73 (0.11)c0.69 (0.41)−0.06 (0.03)b−0.03 (0.09)0.13 (0.02)c0.11 (0.08)Perceived severity
−0.10 (0.03)c−0.16 (0.10)−0.04 (0.01)b−0.03 (0.02)−0.01 (0.01)−0.03 (0.02)Years since the diagnosis
0.19 (0.02)c0.21 (0.08)b−0.08 (0.01)c−0.06 (0.02)c0.07 (0.01)c0.06 (0.02)cTrait anxiety and depression
0.23 (0.03)c0.22 (0.12)0.02 (0.01)b0.01 (0.02)0.03 (0.01)c0.04 (0.02)bTrait stress
aAge and sex adjusted.
bP<.05.
cP<.01.
Individual Fluctuation of Negative Affect and Positive
Affect Over Time
Both the momentary NA and PA of participants fluctuated over
time. We arbitrarily selected 10 participants from those who
completed all 28 assessments to show the individual fluctuation
of affect over time. Specific graphs of NA and PA fluctuation
were constructed for each selected participant in accordance
with momentary and trait variables (Figures 1 and 2 as
examples).
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Figure 1. Individual fluctuation of negative affect over time for the selected participants. NA: negative affect; A to I: selected participants.
Figure 2. Individual fluctuation of positive affect over time for the selected participants. PA: positive affect; A to I: selected participants.
Discussion
Principal Findings
This study used the EMA method to assess and predict
momentary factors associated with momentary mood and stress
in a real-life context in adult patients with MMD. The results
showed that context variables of the participants’ natural
environment affected momentary mood and stress at both the
within-person and between-person levels after adjusting for
participant demographics and disease-specific characteristics
and trait anxiety and depression.
We also identified common variables affecting momentary
mood and stress at both the within-person and between-person
levels and distinguished different variables having different
effects at the within-person and between-person levels.
Participants commonly showed higher NA when being alone
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or at the hospital at both levels. Meanwhile, some factors such
as activities of eating or drinking or resting affected momentary
NA at the between-person level only. Participants commonly
expressed decreased stress when resting or during the weekend
and increased stress at the office and as the time of the day went
by at both levels. Meanwhile, being at the hospital was
associated with higher stress only at the between-person level.
These results showed that different factors at different levels
are associated with NA and stress, although there are numerous
common factors. These factor differences between the two levels
should be considered when designing individualized
interventions to manage the mood and stress of patients with
MMD.
This study also established that an EMA method using a mobile
app could capture individual fluctuations of mood and stress
over time while participants perform their usual daily tasks.
This result is aligned with the result from a previous study that
applied an EMA app using the same scale of the PsyMate to
assess the mood of Dutch patients in an ambulatory mental
health setting [38], presenting the ability to detect changes in
mood over time.
In an additional analysis, we found that patients who had been
diagnosed less than a year ago appeared to be more depressed
than those who were diagnosed more than a year ago. These
results indicate that an emotional care plan with close, regular
monitoring is needed for patients with MMD, especially for
those with higher anxiety and depression, and within a year
after diagnosis. The levels of anxiety and depression of the
participants in this study at baseline were 7.17 (SD 3.38) and
7.14 (SD 3.51) out of 21, respectively. This implies that adults
with MMD may also strive to overcome negative feelings, as
do patients with other cerebrovascular diseases who are at
continuous risk of cerebrovascular hemorrhage and infarction
[40,41].
Perceived stress is a known predictor of depression and
depressive symptoms in patients with stroke [42,43]. The results
of this study also showed that both trait and momentary stress
are significantly associated with momentary mood at both the
within-person and between-person levels. Stress should be
managed, as it triggers negative mood. Negative mood and
stress in patients with cerebrovascular disorders are related to
emotional distress, which threatens health behaviors and drives
patients to avoid health-promoting activities [44].
Perceived social support plays a critical role in buffering stress
and promoting psychological well-being [45-47]. Patients with
MMD should be encouraged to engage in social interactions
with family or self-support groups, as it was shown that being
alone is significantly related to momentary increase in negative
mood at both levels.
Limitations and Future Directions
Our study had limitations. This study included patients who
used Android OS, and those who used other systems were
excluded. In addition, there might be challenges regarding
technical issues and potential malfunctioning of the
configuration, although a helpline was provided by our research
team. These technical points need to be addressed to improve
the EMA survey in the future. In addition, as the patients were
recruited from a tertiary-level hospital in Seoul, patients in
communities or in smaller facilities may differ from this study
population in terms of clinical severity, years since the diagnosis,
or trait mood and stress levels.
Studies on the impact of social support or stress-coping
strategies on mood and stress in MMD warrants further
investigation. EMA methods integrated into momentary
interventions for improving mood and stress could be a
promising future direction in MMD.
Conclusions
In this study, we evaluated the EMA method using a mobile
phone app and demonstrated that the EMA method was able to
capture mood and stress change over time and by assessing
momentary contextual variables. With the identified predictors
affecting mood and stress at two different levels, the results of
this study could provide valuable information for developing
individualized patient-centered interventions for managing the
mood and stress of patients with MMD who are psychologically
vulnerable and whose states cannot be easily assessed in a
real-world environment.
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